Orphan designation: Copanlisib Treatment of marginal zone lymphoma, 24/08/2018 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 May 2026 - 11:31

Orphan designation: Copanlisib Treatment of marginal zone lymphoma, 24/08/2018 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-18-2064

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters